This statistic displays the revenue generated by patented drugs in the prescribed drug market in India from 2008 to 2015. In 2015, patented drugs generated some 2.7 billion U.S. dollars in revenue, up from about 2.2 billion U.S. dollars in 2014.
Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
- Basic Statistic Share of generic pharmaceuticals volume in Norway 2000-2022
- Basic Statistic Dipharma Francis: profit 2016-2022
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Basic Statistic Sales value of pharmaceuticals in Sweden 2013-2022
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Indian pharmaceutical export value FY 2012-2024
- Premium Statistic Generic drugs revenue in prescribed drug market in India 2008-2020
- Premium Statistic U.S. costs saved through generics by therapy 2004-2013
About the region
10
- Premium Statistic Indian pharmaceutical export share FY 2020, by region
- Premium Statistic Distribution of pharmaceutical market revenue in India 2020, by sub segment
- Premium Statistic Annual moving revenue pharmaceutical market India 2018 by segment
- Premium Statistic Lupin's net sales FY 2015-2022
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
Selected statistics
10
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
10
- Premium Statistic Total worldwide prescription drug revenue - projection 2020-2028
- Basic Statistic Definition of specialty drugs by PBMs and pharmacy executives 2011
- Basic Statistic Value share of generic pharmaceuticals market in Czechia 2011-2021
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Basic Statistic Drug cost distribution by drug type in public drug plans Canada 2021/2022
- Basic Statistic Value share of generic pharmaceuticals market in Turkey 2010-2021
- Basic Statistic Generic market value share of community pharmacies in Slovakia 2000-2021
- Basic Statistic Dispensed asthma/COPD medicines in the Netherlands 2014-2022
- Premium Statistic Chile: pharmaceutical market size 2015-2017
- Premium Statistic Colombia: pharmaceutical market size 2015-2017
Related statistics
10
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Basic Statistic Market value of leading molecules in the cardiac segment India FY 2020
- Premium Statistic Value of drugs and pharma imports from China to India 2019, by segment
- Premium Statistic Number of Indian ANDA approvals by the U.S. FDA 2017-2019
- Premium Statistic Rate of approval for Indian pharma ANDA by U.S. FDA 2017-2019
- Premium Statistic Net sales of Indian pharma companies in 2017-2019
Further related statistics
8
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- U.S. branded prescription revenue forecast 2009-2015
Further Content: You might find this interesting as well
Statistics
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- U.S. branded prescription revenue forecast 2009-2015
India Brand Equity Foundation. (January 1, 2017). Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars) [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/712737/india-patented-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. "Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars)." Chart. January 1, 2017. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/712737/india-patented-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. (2017). Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/712737/india-patented-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. "Revenue of Patented Drugs in Prescribed Drug Market in India from 2008 to 2015 (in Billion U.S. Dollars)." Statista, Statista Inc., 1 Jan 2017, https://www.statista.com/statistics/712737/india-patented-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation, Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/712737/india-patented-drugs-revenue-in-prescribed-drug-market/ (last visited March 29, 2024)
Revenue of patented drugs in prescribed drug market in India from 2008 to 2015 (in billion U.S. dollars) [Graph], India Brand Equity Foundation, January 1, 2017. [Online]. Available: https://www.statista.com/statistics/712737/india-patented-drugs-revenue-in-prescribed-drug-market/